Skip to main content
SpringerLink
Log in

First report for the electrochemical determination and proposed mechanism of poly(ADP ribose) polymerase inhibitor and new smart anticancer drug olaparib

  • Original Paper
  • Published:
Monatshefte für Chemie - Chemical Monthly Aims and scope Submit manuscript

Abstract

A sensitive, rapid, and inexpensive electrochemical method with an unmodified carbon paste electrode (CPE) was developed for the first time for voltammetric determination of poly(ADP-Ribose) polymerase (PARP) inhibitor olaparib (OLA) used in the treatment of advanced ovarian cancer, metastatic breast, and prostate cancer. OLA showed an irreversible oxidation peak at physiological pH (pH 7.4) at approximately + 1.31 V by the cyclic voltammetry technique. Using the suitable values of square-wave voltammetric parameters, the CPE showed good linearity in the concentration ranges of 5.8 × 10–7–4.6 × 10–5 mol dm−3 for OLA. The limit of detection and limit of quantification were determined to be 2.9 × 10–8 and 9.7 × 10–8 mol dm−3 for OLA, respectively. Besides its high stability and reproducibility, the response of OLA at CPE was not affected in the presence of dopamine, uric acid, and ascorbic acid. The developed electrochemical method has been successfully applied for the detection of OLA in the spiked human urine sample.

Graphical abstract

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6

Similar content being viewed by others

References

  1. Konstantinopoulos PA, Lheureux S, Moore KN (2020) Am Soc Clin Oncol Educ Book 40:e116

    Article  Google Scholar 

  2. Palve V, Knezevic CE, Bejan DS, Luo Y, Li X, Novakova S, Welsh EA, Fang B, Kinose F, Haura EB, Monteiro AN, Koomen JM, Cohen MS, Lawrence HR, Rix U (2022) Cell Chem Bio 29:202

    Article  CAS  Google Scholar 

  3. Ricks TK, Chiu HJ, Ison G, Kim G, McKee AE, Kluetz P, Pazdur R (2015) Front Oncol 5:222

    Article  PubMed  PubMed Central  Google Scholar 

  4. Rudolph J, Jung K, Luger K (2022) Proc Natl Acad Sci 119:e2121979119

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  5. Lu Z, Mao W, Yang H, Santiago-O’Farrill JM, Rask PJ, Mondal J, Bast Jr RC (2022) Clin Investig 132:e146471

  6. Deeks ED (2015) Drugs 75:231

    Article  CAS  PubMed  Google Scholar 

  7. Bruin MAC, Korse CM, van Wijnen B, de Jong VMT, Linn SC, van Triest B, Rosing H, Beijnen JH, van den Broek D, Huitema ADR (2021) Eur J Clin Pharmacol 77:179

    Article  CAS  PubMed  Google Scholar 

  8. Plummer R, Swaisland H, Leunen K, van Herpen CM, Jerusalem G, De Grève J, Molife L (2015) Can Chemot Pharmacol 76:723

    Article  CAS  Google Scholar 

  9. Mateo J, Porta N, Bianchini D, McGovern U, Elliott T, Jones R, de Bono JS (2020) Lancet Oncol 21:162

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  10. Boussios S, Karihtala P, Moschetta M, Karathanasi A, Sadauskaite A, Rassy E, Pavlidis N (2019) Diagnostics 9:87

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  11. Friedlander M, Banerjee S, Mileshkin L, Scott C, Shannon C, Goh J (2016) Asia-Pacific J Cli Oncol 12:323

    Article  Google Scholar 

  12. Butler T, Maravent S, Boisselle J, Valdes J, Fellner C (2015) Pharm Therap 40:191

    Google Scholar 

  13. Pathade AD, Kommineni N, Bulbake U, Thummar MM, Samanthula G, Khan W (2019) AAPS Pharm Sci Tech 20:1

    Article  CAS  Google Scholar 

  14. Rolfo C, Isambert N, Italiano A, Molife LR, Schellens JHM, Blay JY, Decaens T, Kristeleit R, Rosmorduc O, Demlova R, Lee MA, Ravaud A, Kopeckova K, Learoyd M, Bannister W, Locker G, de Vos-Geelen J (2020) Br J Clin Pharmacol 86:1807

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  15. https://www.accessdata.fda.gov/drugsatfda_docs/label/2014/206162lbl.pdf. Accessed 28 Mar 2023

  16. Roth J, Peer CJ, Mannargudi B, Swaisland H, Lee JM, Kohn EC, Figg WD (2014) Chromat 1:82

    Article  Google Scholar 

  17. Daumar P, Dufour R, Dubois C, Penault-Llorca F, Bamdad M, Mounetou E (2018) J Pharm Biomed Anal 152:74

    Article  CAS  PubMed  Google Scholar 

  18. Guibbal F, Isenegger PG, Wilson TC, Pacelli A, Mahaut D, Sap JB, Gouverneur V (2020) Nat Prot 15:1525

    Article  CAS  Google Scholar 

  19. Chaudhary A, Tonk R, Dagur P, Dey S, Ghosh M (2022) Turk J Pharm Sci 19:488

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  20. Kavitapu D, Maruthapillai A, Devikala S, Selvi JA, Tamilselvi M, Mahapatra S, Tyagi PK (2019) Mater Today Proc 14:492

    Article  CAS  Google Scholar 

  21. Nalanda RB, Srinivasa Rao A, Sankar DG (2019) Anal Chem Lett 9:526

    Article  CAS  Google Scholar 

  22. Vysyaraju NR, Paul M, Ch S, Ghosh B, Biswas S (2022) J Drug Targeting 30:1088

    CAS  Google Scholar 

  23. Su G, Qin L, Su X, Tao C, Wei Y (2020) Biomed Chrom 34:e4791

    CAS  Google Scholar 

  24. Nijenhuis CM, Lucas L, Rosing H, Schellens JHM, Beijnen JH (2013) J Chrom B 940:121

    Article  CAS  Google Scholar 

  25. Jolibois J, Schmitt A, Royer B (2019) J Chrom B 1132:121844

    Article  CAS  Google Scholar 

  26. Morosi L, Matteo C, Ceruti T, Giordano S, Ponzo M, Frapolli R, Ubezio P (2020) Int J Biol Sci 16:1363

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  27. Ottria R, Ravelli A, Miceli M, Casati S, Orioli M, Ciuffreda P (2019) Molecules 24:989

    Article  PubMed  PubMed Central  Google Scholar 

  28. Krens SD, van der Meulen E, Jansman FG, Burger DM, van Erp NP (2020) Bio Chrom 34:e4758

    CAS  Google Scholar 

  29. Thummar M, Kuswah BS, Samanthula G, Bulbake U, Gour J, Khan W (2018) J Pharm Biomed Anal 160:89

    Article  CAS  PubMed  Google Scholar 

  30. Pressiat C, Huynh HH, Ple A, Sauvageon H, Madelaine I, Chougnet C, Goldwirt L (2018) Ther Drug Monit 40:337

    Article  CAS  PubMed  Google Scholar 

  31. Aydin I, Akgun H, Pınar PT (2019) ChemistrySelect 4:9966

    Article  CAS  Google Scholar 

  32. Pınar PT, Yardım Y, Şentürk Z (2018) Sens Actuators B Chem 273:1463

    Article  Google Scholar 

  33. Arvand M, Pourhabib A (2021) J Anal Chem 76:518

    Article  Google Scholar 

  34. Mehmeti E, Stanković DM, Chaiyo S, Švorc L, Kalcher K (2016) Microchim Acta 183:1619

    Article  CAS  Google Scholar 

  35. Özok Hİ, Allahverdiyeva S, Yardım Y, Şentürk Z (2022) Electroanalysis 34:1487

    Article  Google Scholar 

  36. Doulache M, Kaya SI, Cetinkaya A, Bakirhan NK, Trari M, Ozkan SA (2021) Micro J 170:106717

    CAS  Google Scholar 

  37. Cinková K, Kianičková K, Stanković DM, Vojs M, Marton M, Švorc L (2018) Anal Methods 10:991

    Article  Google Scholar 

  38. Pressiat C, Huynh HH, Pl´e A, Sauvageon H, Madelaine I, Chougnet C, Le Maignan C, Mourah S, Goldwirt L (2018) Ther Drug Monit 40:337

  39. Sparidans RW, Martens I, Valkenburg-van Iersel LBJ, den Hartigh J, Schellens JHM, Beijnen JH (2011) J Chromatogr B 879:1851

    Article  CAS  Google Scholar 

  40. Jolibois J, Schmitt A, Royer B (2019) J Chromatogr B 1132:121844

    Article  CAS  Google Scholar 

  41. Bruin MAC, de Vries N, Lucas L, Rosing H, Huitema ADR, Beijnen JH (2020) J Chromatogr B 1138:121925

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Analytical Chemistry, Faculty of Pharmacy, Van Yuzuncu Yil University, 65080, Van, Turkey

    Dicle Göktaş & Pınar Talay Pınar

Authors
  1. Dicle Göktaş
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Pınar Talay Pınar
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Pınar Talay Pınar.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Göktaş, D., Talay Pınar, P. First report for the electrochemical determination and proposed mechanism of poly(ADP ribose) polymerase inhibitor and new smart anticancer drug olaparib. Monatsh Chem 154, 577–584 (2023). https://doi.org/10.1007/s00706-023-03069-0

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00706-023-03069-0

Keywords

Search

Navigation